Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
DraftKings Inc ha un obiettivo di prezzo consensuale di $55.14, basato sulle valutazioni degli ultimi 29 analisti. Il massimo è $61 emesso da JP Morgan il febbraio 18, 2025, mentre il minimo è $48 emesso da BMO Capital il ottobre 16, 2024. Le ultime 3 valutazioni degli analisti sono state pubblicate da Jefferies, Barclays e Benchmark il agosto 8, 2025, agosto 8, 2025 e agosto 7, 2025. Con un obiettivo di prezzo medio di $53.67 tra Jefferies, Barclays e Benchmark, c'è un cambiamento implicito del 23.94% upside per DraftKings Inc secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/08/2025 | 24.71% | Jefferies | $53 → $54 | Maintains | Buy | |||
08/08/2025 | 24.71% | Barclays | $51 → $54 | Maintains | Overweight | |||
08/07/2025 | 22.4% | Benchmark | $50 → $53 | Maintains | Buy | |||
07/25/2025 | 38.57% | Susquehanna | $52 → $60 | Maintains | Positive | |||
07/18/2025 | 17.78% | Barclays | $48 → $51 | Maintains | Overweight | |||
07/16/2025 | 17.78% | Stifel | $53 → $51 | Maintains | Buy | |||
07/16/2025 | 27.02% | Truist Securities | $50 → $55 | Maintains | Buy | |||
07/15/2025 | 15.47% | Benchmark | $45 → $50 | Maintains | Buy | |||
07/11/2025 | 20.09% | Morgan Stanley | $51 → $52 | Maintains | Overweight | |||
07/03/2025 | 22.4% | Jefferies | $60 → $53 | Maintains | Buy | |||
07/01/2025 | 33.95% | Citigroup | $55 → $58 | Maintains | Buy | |||
06/23/2025 | 15.47% | JP Morgan | → $50 | Initiates | → Overweight | |||
06/05/2025 | 15.47% | JMP Securities | $54 → $50 | Maintains | Market Outperform | |||
05/30/2025 | 17.78% | Morgan Stanley | $53 → $51 | Maintains | Overweight | |||
05/12/2025 | 24.71% | JMP Securities | $57 → $54 | Maintains | Market Perform | |||
05/12/2025 | 20.09% | Susquehanna | $42 → $52 | Maintains | Positive | |||
05/12/2025 | 22.4% | Macquarie | $55 → $53 | Maintains | Outperform | |||
05/12/2025 | 33.95% | Mizuho | $59 → $58 | Maintains | Outperform | |||
05/12/2025 | 10.85% | Barclays | $50 → $48 | Maintains | Overweight | |||
05/12/2025 | 38.57% | Guggenheim | $61 → $60 | Maintains | Buy | |||
05/12/2025 | 38.57% | Needham | $65 → $60 | Maintains | Buy | |||
05/09/2025 | 15.47% | B of A Securities | $60 → $50 | Maintains | Buy | |||
05/09/2025 | 50.12% | Needham | $65 → $65 | Reiterates | Buy → Buy | |||
04/28/2025 | 36.26% | Mizuho | $62 → $59 | Maintains | Outperform | |||
04/25/2025 | 27.02% | Citigroup | $65 → $55 | Maintains | Buy | |||
04/24/2025 | 27.02% | TD Securities | $60 → $55 | Maintains | Buy | |||
04/23/2025 | 15.47% | Truist Securities | $60 → $50 | Maintains | Buy | |||
04/22/2025 | 15.47% | Barclays | $60 → $50 | Maintains | Overweight | |||
04/22/2025 | 22.4% | Stifel | $57 → $53 | Maintains | Buy | |||
04/22/2025 | 20.09% | BTIG | $64 → $52 | Maintains | Buy | |||
04/10/2025 | 40.88% | Guggenheim | $62 → $61 | Maintains | Buy | |||
04/07/2025 | 50.12% | Needham | $65 → $65 | Reiterates | Buy → Buy | |||
04/02/2025 | 31.64% | JMP Securities | $60 → $57 | Maintains | Market Perform | |||
04/02/2025 | 31.64% | Citizens Capital Markets | $60 → $57 | Maintains | Market Outperform | |||
03/21/2025 | 38.57% | Citizens Capital Markets | $60 → $60 | Reiterates | Market Outperform → Market Outperform | |||
03/10/2025 | 17.78% | Benchmark | $44 → $51 | Maintains | Buy | |||
02/24/2025 | 22.4% | Morgan Stanley | $49 → $53 | Maintains | Overweight | |||
02/18/2025 | 40.88% | JP Morgan | $53 → $61 | Maintains | Overweight | |||
02/18/2025 | 38.57% | JMP Securities | $50 → $60 | Maintains | Market Outperform | |||
02/18/2025 | 38.57% | Wells Fargo | $53 → $60 | Maintains | Overweight | |||
02/18/2025 | 38.57% | Piper Sandler | $48 → $60 | Reiterates | Overweight → Overweight | |||
02/18/2025 | 38.57% | Barclays | $50 → $60 | Maintains | Overweight | |||
02/18/2025 | 38.57% | Truist Securities | $50 → $60 | Maintains | Buy | |||
02/18/2025 | 31.64% | Stifel | $48 → $57 | Maintains | Buy | |||
02/18/2025 | 50.12% | Needham | $60 → $65 | Maintains | Buy | |||
02/14/2025 | 17.78% | Benchmark | $44 → $51 | Maintains | Buy | |||
02/14/2025 | 15.47% | JMP Securities | $50 → $50 | Reiterates | Market Outperform → Market Outperform | |||
02/14/2025 | 38.57% | Canaccord Genuity | $54 → $60 | Maintains | Buy | |||
02/14/2025 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
02/07/2025 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
02/04/2025 | 17.78% | TD Cowen | $55 → $51 | Maintains | Buy | |||
01/08/2025 | 24.71% | Susquehanna | $56 → $54 | Maintains | Positive | |||
01/07/2025 | 1.62% | Benchmark | $44 → $44 | Reiterates | Buy → Buy | |||
01/06/2025 | 15.47% | JMP Securities | $52 → $50 | Maintains | Market Outperform | |||
12/13/2024 | 22.4% | JP Morgan | $47 → $53 | Maintains | Overweight | |||
11/12/2024 | 27.02% | TD Cowen | $50 → $55 | Maintains | Buy | |||
11/11/2024 | 22.4% | Wells Fargo | $52 → $53 | Maintains | Overweight | |||
11/11/2024 | 17.78% | Macquarie | $50 → $51 | Maintains | Outperform | |||
11/11/2024 | 15.47% | Barclays | $45 → $50 | Maintains | Overweight | |||
11/11/2024 | 20.09% | JMP Securities | $51 → $52 | Maintains | Market Outperform | |||
11/11/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
11/08/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
10/22/2024 | 10.85% | Morgan Stanley | $47 → $48 | Maintains | Overweight | |||
10/18/2024 | 43.19% | Mizuho | $54 → $62 | Maintains | Outperform | |||
10/17/2024 | 20.09% | Wells Fargo | $47 → $52 | Maintains | Overweight | |||
10/16/2024 | 10.85% | BMO Capital | $48 → $48 | Reiterates | Outperform → Outperform | |||
10/14/2024 | 17.78% | JMP Securities | $51 → $51 | Reiterates | Market Outperform → Market Outperform | |||
10/07/2024 | 1.62% | Benchmark | $44 → $44 | Reiterates | Buy → Buy | |||
10/07/2024 | 15.47% | Susquehanna | $48 → $50 | Maintains | Positive | |||
10/04/2024 | 3.93% | Barclays | $43 → $45 | Maintains | Overweight | |||
09/26/2024 | 24.71% | JP Morgan | $48 → $54 | Maintains | Overweight | |||
09/23/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
09/16/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
09/11/2024 | 8.55% | Morgan Stanley | $47 → $47 | Reiterates | Overweight → Overweight | |||
09/09/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
09/04/2024 | 33.95% | UBS | $56 → $58 | Maintains | Buy | |||
09/04/2024 | 10.85% | Susquehanna | $47 → $48 | Maintains | Positive | |||
09/03/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
08/26/2024 | 15.47% | Macquarie | $50 → $50 | Maintains | Outperform | |||
08/20/2024 | 1.62% | Benchmark | $41 → $44 | Maintains | Buy | |||
08/19/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
08/14/2024 | 15.47% | Truist Securities | $50 → $50 | Maintains | Buy | |||
08/14/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
08/13/2024 | 8.55% | Morgan Stanley | $51 → $47 | Maintains | Overweight | |||
08/05/2024 | -0.69% | Barclays | $53 → $43 | Maintains | Overweight | |||
08/05/2024 | 15.47% | Macquarie | $52 → $50 | Maintains | Outperform | |||
08/05/2024 | 27.02% | Oppenheimer | $58 → $55 | Maintains | Outperform | |||
08/05/2024 | 15.47% | Truist Securities | $53 → $50 | Maintains | Buy | |||
08/05/2024 | 10.85% | Stifel | $50 → $48 | Reiterates | Buy → Buy | |||
08/05/2024 | 8.55% | Wells Fargo | $53 → $47 | Maintains | Overweight | |||
08/05/2024 | 24.71% | Goldman Sachs | $60 → $54 | Maintains | Buy | |||
08/05/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
08/02/2024 | -5.31% | Benchmark | $52 → $41 | Maintains | Buy | |||
08/02/2024 | 10.85% | BMO Capital | $54 → $48 | Maintains | Outperform | |||
08/01/2024 | 8.55% | Susquehanna | $49 → $47 | Maintains | Positive | |||
07/24/2024 | 38.57% | Needham | $60 → $60 | Reiterates | Buy → Buy | |||
07/22/2024 | 15.47% | B of A Securities | $54 → $50 | Maintains | Buy | |||
07/18/2024 | 20.09% | Macquarie | $54 → $52 | Maintains | Outperform | |||
07/18/2024 | 22.4% | Truist Securities | $55 → $53 | Maintains | Buy | |||
07/10/2024 | 22.4% | Barclays | $54 → $53 | Maintains | Overweight |
L'ultimo obiettivo di prezzo per DraftKings (NASDAQ:DKNG) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $54.00 prevedendo che DKNG raggiunga rise entro 12 mesi (un possibile 24.71% upside).
L'ultima valutazione degli analisti per DraftKings (NASDAQ:DKNG) è stato fornita da Jefferies e DraftKings mantenuto il suo rating buy.
Non c'è un ultimo aggiornamento per DraftKings.
Non esiste una revisione finale al ribasso per DraftKings.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di DraftKings e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di DraftKings è stata depositata il agosto 8, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a agosto 8, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di DraftKings (DKNG) è stata una mantenuto con un obiettivo di prezzo di $53.00 a $54.00. Il prezzo attuale a cui DraftKings (DKNG) è scambiato è $43.30, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.